世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

臨床試験用イメージングの世界市場規模、現状、予測 2022-2028年


Global Clinical Trial Imaging Market Size, Status and Forecast 2022-2028

市場の分析と洞察。臨床試験用イメージングの世界市場 臨床試験用イメージングの世界市場規模は、2021年の1億3744万米ドルから2028年には2億1988万米ドルに達すると予測され、2022年から2028年の間に6.71%のCAGR... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年7月12日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場の分析と洞察。臨床試験用イメージングの世界市場
臨床試験用イメージングの世界市場規模は、2021年の1億3744万米ドルから2028年には2億1988万米ドルに達すると予測され、2022年から2028年の間に6.71%のCAGRで推移するとされています。

この健康危機による経済変化を十分に考慮すると、2021年に臨床試験イメージング世界市場の30.61％を占めたインハウスイメージングサービスは、2028年までに5億9,879万米ドルの価値を持ち、2022年から2028年の間に改訂された5.05％のCAGRで成長すると予測されています。一方、製薬会社セグメントは、この予測期間を通してCAGR7.33%に変化しています。
中国の臨床試験イメージング市場規模は2021年に1億3,653万米ドル、北米と欧州の臨床試験イメージング市場はそれぞれ4億5,963万米ドル、3億7,496万米ドルであった。2021年の北米の割合は33.32％、中国とヨーロッパはそれぞれ9.90％と27.18％で、中国の割合は2028年には11.30％に達し、分析期間を通じてCAGR8.54％をたどると予測されている。

本レポートは、業界標準の分析精度と高いデータ整合性により、世界の臨床試験イメージング市場で利用可能な主要機会を明らかにし、プレイヤーが市場での強力な地位を獲得するのに役立つ素晴らしい試みとなっています。本レポートの購入者は、世界の臨床試験イメージング市場の全体規模（収益ベース）を含む、検証済みで信頼性の高い市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の臨床試験イメージング市場における持続的な成功を確実にするために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界の臨床試験イメージング市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。

世界の臨床試験用イメージングの範囲と市場規模
臨床試験イメージング市場は、プレイヤー別、地域（国）別、タイプ別、用途別に分類されています。世界の臨床試験イメージング市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017-2028年の期間において、タイプ別の収益と予測、アプリケーション別の収益と予測に焦点を当てます。

企業別
クラリオ
アイコン
マクラーレン
パレクセル
バイオテレメトリー
プロスキャンイメージング
イメージングエンドポイント
ラディアント・セイジ
マイクロン社
イントリンシック・イメージング
メディアン・テクノロジーズ
カーディオバスキュラー・イメージング・テクノロジー
バヌークメディカル
IXICO

タイプ別セグメント
インハウスイメージングサービス
セントラルイメージングサービス

用途別セグメント
製薬会社
バイオテクノロジー企業
学術機関
その他

地域別
北アメリカ
米国
カナダ
メキシコ
アジア・パシフィック
中国
日本
インド
東南アジア
韓国
オーストラリア
その他のアジア
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他の欧州
南米
ブラジル
南米のその他
中東・アフリカ
GCC諸国
トルコ
南アフリカ
MEAの残りの地域

ページTOPに戻る


目次

1 REPORT OVERVIEW 1
1.1 STUDY SCOPE 1
1.2 MARKET ANALYSIS BY TYPE 2
1.2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028 2
1.2.2 IN-HOUSE IMAGING SERVICE 3
1.2.3 CENTRAL IMAGING SERVICE 4
1.3 MARKET BY APPLICATION 5
1.3.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028 5
1.3.2 PHARMACEUTICAL COMPANIES 7
1.3.3 BIOTECHNOLOGY COMPANIES 7
1.3.4 ACADEMIC INSTITUTES 7
1.3.5 OTHERS 8
1.4 STUDY OBJECTIVES 8
1.5 YEARS CONSIDERED 9
2 GLOBAL GROWTH TRENDS 10
2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET PERSPECTIVE (2017-2028) 10
2.2 CLINICAL TRIAL IMAGING GROWTH TRENDS BY REGION 11
2.2.1 CLINICAL TRIAL IMAGING MARKET SIZE BY REGION: 2017 VS 2021 VS 2028 11
2.2.2 CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY REGION (2017-2022) 12
2.2.3 CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY REGION (2023-2028) 13
2.3 CLINICAL TRIAL IMAGING MARKET DYNAMICS 14
2.3.1 CLINICAL TRIAL IMAGING INDUSTRY TRENDS 14
2.3.2 CLINICAL TRIAL IMAGING MARKET DRIVERS 14
2.3.3 CLINICAL TRIAL IMAGING MARKET CHALLENGES 15
2.3.4 PORTER鈥橲 FIVE FORCES ANALYSIS 15
3 COMPETITION LANDSCAPE BY KEY PLAYERS 17
3.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE 17
3.1.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE (2017-2022) 17
3.1.2 GLOBAL CLINICAL TRIAL IMAGING REVENUE MARKET SHARE BY PLAYERS (2017-2022) 18
3.2 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 19
3.3 PLAYERS COVERED: RANKING BY CLINICAL TRIAL IMAGING REVENUE 19
3.4 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO 20
3.4.1 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO (CR5) 20
3.4.2 GLOBAL TOP 3 AND TOP 5 COMPANIES BY CLINICAL TRIAL IMAGING REVENUE IN 2021 21
3.5 CLINICAL TRIAL IMAGING KEY PLAYERS HEAD OFFICE AND AREA SERVED 22
3.6 ESTABLISHED DATE OF CLINICAL TRIAL IMAGING MARKET PLAYERS 23
3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS 23
4 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY TYPE 25
4.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY TYPE (2017-2022) 25
4.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY TYPE (2023-2028) 25
5 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY APPLICATION 27
5.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY APPLICATION (2017-2022) 27
5.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 28
6 NORTH AMERICA 29
6.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 29
6.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 29
6.2.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 29
6.2.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 30
6.2.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 30
6.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 31
6.3.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 31
6.3.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 31
6.3.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 32
6.4 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 32
6.4.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 32
6.4.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY COUNTRY (2023-2028) 33
6.4.3 UNITED STATES 34
6.4.4 CANADA 34
6.4.5 MEXICO 35
7 EUROPE 36
7.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 36
7.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 36
7.2.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 36
7.2.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 37
7.2.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 37
7.3 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 38
7.3.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 38
7.3.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 38
7.3.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 39
7.4 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 39
7.4.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 39
7.4.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 40
7.4.3 GERMANY 41
7.4.4 FRANCE 41
7.4.5 U.K. 42
7.4.6 ITALY 42
7.4.7 RUSSIA 43
7.4.8 NORDIC COUNTRIES 43
8 ASIA-PACIFIC 44
8.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 44
8.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 44
8.2.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 44
8.2.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 45
8.2.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 45
8.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 46
8.3.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 46
8.3.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 46
8.3.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 47
8.4 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION 47
8.4.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2017-2022) 47
8.4.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2023-2028) 48
8.4.3 CHINA 49
8.4.4 JAPAN 49
8.4.5 KOREA 50
8.4.6 SOUTHEAST ASIA 50
8.4.7 INDIA 51
8.4.8 AUSTRALIA 51
9 SOUTH AMERICA 52
9.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 52
9.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 52
9.2.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 52
9.2.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 53
9.2.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 53
9.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 54
9.3.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 54
9.3.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 54
9.3.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 55
9.4 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 55
9.4.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 55
9.4.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 56
9.4.3 BRAZIL 57
10 MIDDLE EAST & AFRICA 58
10.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 58
10.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 58
10.2.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 58
10.2.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 59
10.2.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 59
10.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 60
10.3.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 60
10.3.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 60
10.3.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 61
10.4 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 61
10.4.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 61
10.4.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 62
10.4.3 GCC COUNTRIES 63
10.4.4 TURKEY 63
10.4.5 SOUTH AFRICA 64
11 KEY PLAYERS PROFILES 65
11.1 CLARIO 65
11.1.1 CLARIO COMPANY DETAILS 65
11.1.2 CLARIO BUSINESS OVERVIEW 65
11.1.3 CLARIO CLINICAL TRIAL IMAGING INTRODUCTION 66
11.1.4 CLARIO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 68
11.1.5 CLARIO RECENT DEVELOPMENT 69
11.2 ICON 69
11.2.1 ICON COMPANY DETAILS 69
11.2.2 ICON BUSINESS OVERVIEW 70
11.2.3 ICON CLINICAL TRIAL IMAGING INTRODUCTION 70
11.2.4 ICON REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 71
11.2.5 ICON RECENT DEVELOPMENT 72
11.3 MCLAREN 72
11.3.1 MCLAREN COMPANY DETAILS 72
11.3.2 MCLAREN BUSINESS OVERVIEW 73
11.3.3 MCLAREN CLINICAL TRIAL IMAGING INTRODUCTION 73
11.3.4 MCLAREN REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 74
11.3.5 MCLAREN RECENT DEVELOPMENT 75
11.4 PAREXEL 75
11.4.1 PAREXEL COMPANY DETAILS 75
11.4.2 PAREXEL BUSINESS OVERVIEW 76
11.4.3 PAREXEL CLINICAL TRIAL IMAGING INTRODUCTION 76
11.4.4 PAREXEL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 77
11.4.5 PAREXEL RECENT DEVELOPMENT 78
11.5 BIOTELEMETRY 79
11.5.1 BIOTELEMETRY COMPANY DETAILS 79
11.5.2 BIOTELEMETRY BUSINESS OVERVIEW 79
11.5.3 BIOTELEMETRY CLINICAL TRIAL IMAGING INTRODUCTION 79
11.5.4 BIOTELEMETRY REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 80
11.5.5 BIOTELEMETRY RECENT DEVELOPMENT 81
11.6 PROSCAN IMAGING 81
11.6.1 PROSCAN IMAGING COMPANY DETAILS 81
11.6.2 PROSCAN IMAGING BUSINESS OVERVIEW 81
11.6.3 PROSCAN IMAGING CLINICAL TRIAL IMAGING INTRODUCTION 82
11.6.4 PROSCAN IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 83
11.6.5 PROSCAN IMAGING RECENT DEVELOPMENT 84
11.7 IMAGING ENDPOINTS 84
11.7.1 IMAGING ENDPOINTS COMPANY DETAILS 84
11.7.2 IMAGING ENDPOINTS BUSINESS OVERVIEW 85
11.7.3 IMAGING ENDPOINTS CLINICAL TRIAL IMAGING INTRODUCTION 85
11.7.4 IMAGING ENDPOINTS REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 87
11.7.5 IMAGING ENDPOINTS RECENT DEVELOPMENT 87
11.8 RADIANT SAGE 88
11.8.1 RADIANT SAGE COMPANY DETAILS 88
11.8.2 RADIANT SAGE BUSINESS OVERVIEW 88
11.8.3 RADIANT SAGE CLINICAL TRIAL IMAGING INTRODUCTION 88
11.8.4 RADIANT SAGE REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 89
11.9 MICRON, INC. 90
11.9.1 MICRON, INC. COMPANY DETAILS 90
11.9.2 MICRON, INC. BUSINESS OVERVIEW 90
11.9.3 MICRON, INC. CLINICAL TRIAL IMAGING INTRODUCTION 90
11.9.4 MICRON, INC. REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 91
11.9.5 MICRON, INC. RECENT DEVELOPMENT 92
11.10 INTRINSIC IMAGING 92
11.10.1 INTRINSIC IMAGING COMPANY DETAILS 92
11.10.2 INTRINSIC IMAGING BUSINESS OVERVIEW 93
11.10.3 INTRINSIC IMAGING CLINICAL TRIAL IMAGING INTRODUCTION 93
11.10.4 INTRINSIC IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 94
11.10.5 INTRINSIC IMAGING RECENT DEVELOPMENT 94
11.11 MEDIAN TECHNOLOGIES 95
11.11.1 MEDIAN TECHNOLOGIES COMPANY DETAILS 95
11.11.2 MEDIAN TECHNOLOGIES BUSINESS OVERVIEW 95
11.11.3 MEDIAN TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION 95
11.11.4 MEDIAN TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 96
11.11.5 MEDIAN TECHNOLOGIES RECENT DEVELOPMENT 97
11.12 CARDIOVASCULAR IMAGING TECHNOLOGIES 97
11.12.1 CARDIOVASCULAR IMAGING TECHNOLOGIES COMPANY DETAILS 97
11.12.2 CARDIOVASCULAR IMAGING TECHNOLOGIES BUSINESS OVERVIEW 98
11.12.3 CARDIOVASCULAR IMAGING TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION 98
11.12.4 CARDIOVASCULAR IMAGING TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 99
11.13 BANOOK MEDICAL 100
11.13.1 BANOOK MEDICAL COMPANY DETAILS 100
11.13.2 BANOOK MEDICAL BUSINESS OVERVIEW 101
11.13.3 BANOOK MEDICAL CLINICAL TRIAL IMAGING INTRODUCTION 101
11.13.4 BANOOK MEDICAL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 101
11.13.5 BANOOK MEDICAL RECENT DEVELOPMENT 102
11.14 IXICO 102
11.14.1 IXICO COMPANY DETAILS 102
11.14.2 IXICO BUSINESS OVERVIEW 103
11.14.3 IXICO CLINICAL TRIAL IMAGING INTRODUCTION 103
11.14.4 IXICO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 104
11.14.5 IXICO RECENT DEVELOPMENT 105
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 106
13 APPENDIX 108
13.1 RESEARCH METHODOLOGY 108
13.1.1 METHODOLOGY/RESEARCH APPROACH 108
13.1.2 DATA SOURCE 111
13.2 DISCLAIMER 114
13.3 AUTHOR DETAILS 114

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Clinical Trial Imaging Market
The global Clinical Trial Imaging market size is projected to reach US$ 2197.88 million by 2028, from US$ 1379.44 million in 2021, at a CAGR of 6.71% during 2022-2028.

Fully considering the economic change by this health crisis, In-house Imaging Service accounting for 30.61% of the Clinical Trial Imaging global market in 2021, is projected to value US$ 598.79 million by 2028, growing at a revised 5.05% CAGR between 2022 and 2028. While Pharmaceutical Companies segment is altered to an 7.33% CAGR throughout this forecast period.
China Clinical Trial Imaging market size was US$ 136.53 million in 2021, while the North America and Europe Clinical Trial Imaging were US$ 459.63 million and US$ 374.96 million, severally. The proportion of the North America was 33.32% in 2021, while China and Europe were 9.90% and 27.18% respectively, and it is predicted that China proportion will reach 11.30% in 2028, trailing a CAGR of 8.54% through the analysis period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Trial Imaging market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Trial Imaging market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Trial Imaging market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Trial Imaging market.

Global Clinical Trial Imaging Scope and Market Size
Clinical Trial Imaging market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Trial Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company
Clario
ICON
McLaren
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO

Segment by Type
In-house Imaging Service
Central Imaging Service

Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others

By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
India
Southeast Asia
Korea
Australia
Rest of Asia
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
South Africa
Rest of MEA



ページTOPに戻る


Table of Contents

1 REPORT OVERVIEW 1
1.1 STUDY SCOPE 1
1.2 MARKET ANALYSIS BY TYPE 2
1.2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028 2
1.2.2 IN-HOUSE IMAGING SERVICE 3
1.2.3 CENTRAL IMAGING SERVICE 4
1.3 MARKET BY APPLICATION 5
1.3.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028 5
1.3.2 PHARMACEUTICAL COMPANIES 7
1.3.3 BIOTECHNOLOGY COMPANIES 7
1.3.4 ACADEMIC INSTITUTES 7
1.3.5 OTHERS 8
1.4 STUDY OBJECTIVES 8
1.5 YEARS CONSIDERED 9
2 GLOBAL GROWTH TRENDS 10
2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET PERSPECTIVE (2017-2028) 10
2.2 CLINICAL TRIAL IMAGING GROWTH TRENDS BY REGION 11
2.2.1 CLINICAL TRIAL IMAGING MARKET SIZE BY REGION: 2017 VS 2021 VS 2028 11
2.2.2 CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY REGION (2017-2022) 12
2.2.3 CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY REGION (2023-2028) 13
2.3 CLINICAL TRIAL IMAGING MARKET DYNAMICS 14
2.3.1 CLINICAL TRIAL IMAGING INDUSTRY TRENDS 14
2.3.2 CLINICAL TRIAL IMAGING MARKET DRIVERS 14
2.3.3 CLINICAL TRIAL IMAGING MARKET CHALLENGES 15
2.3.4 PORTER鈥橲 FIVE FORCES ANALYSIS 15
3 COMPETITION LANDSCAPE BY KEY PLAYERS 17
3.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE 17
3.1.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE (2017-2022) 17
3.1.2 GLOBAL CLINICAL TRIAL IMAGING REVENUE MARKET SHARE BY PLAYERS (2017-2022) 18
3.2 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 19
3.3 PLAYERS COVERED: RANKING BY CLINICAL TRIAL IMAGING REVENUE 19
3.4 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO 20
3.4.1 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO (CR5) 20
3.4.2 GLOBAL TOP 3 AND TOP 5 COMPANIES BY CLINICAL TRIAL IMAGING REVENUE IN 2021 21
3.5 CLINICAL TRIAL IMAGING KEY PLAYERS HEAD OFFICE AND AREA SERVED 22
3.6 ESTABLISHED DATE OF CLINICAL TRIAL IMAGING MARKET PLAYERS 23
3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS 23
4 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY TYPE 25
4.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY TYPE (2017-2022) 25
4.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY TYPE (2023-2028) 25
5 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY APPLICATION 27
5.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY APPLICATION (2017-2022) 27
5.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 28
6 NORTH AMERICA 29
6.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 29
6.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 29
6.2.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 29
6.2.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 30
6.2.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 30
6.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 31
6.3.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 31
6.3.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 31
6.3.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 32
6.4 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 32
6.4.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 32
6.4.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY COUNTRY (2023-2028) 33
6.4.3 UNITED STATES 34
6.4.4 CANADA 34
6.4.5 MEXICO 35
7 EUROPE 36
7.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 36
7.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 36
7.2.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 36
7.2.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 37
7.2.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 37
7.3 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 38
7.3.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 38
7.3.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 38
7.3.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 39
7.4 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 39
7.4.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 39
7.4.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 40
7.4.3 GERMANY 41
7.4.4 FRANCE 41
7.4.5 U.K. 42
7.4.6 ITALY 42
7.4.7 RUSSIA 43
7.4.8 NORDIC COUNTRIES 43
8 ASIA-PACIFIC 44
8.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 44
8.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 44
8.2.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 44
8.2.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 45
8.2.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 45
8.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 46
8.3.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 46
8.3.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 46
8.3.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 47
8.4 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION 47
8.4.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2017-2022) 47
8.4.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2023-2028) 48
8.4.3 CHINA 49
8.4.4 JAPAN 49
8.4.5 KOREA 50
8.4.6 SOUTHEAST ASIA 50
8.4.7 INDIA 51
8.4.8 AUSTRALIA 51
9 SOUTH AMERICA 52
9.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 52
9.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 52
9.2.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 52
9.2.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 53
9.2.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 53
9.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 54
9.3.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 54
9.3.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 54
9.3.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 55
9.4 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 55
9.4.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 55
9.4.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 56
9.4.3 BRAZIL 57
10 MIDDLE EAST & AFRICA 58
10.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028) 58
10.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE 58
10.2.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022) 58
10.2.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028) 59
10.2.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028) 59
10.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION 60
10.3.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022) 60
10.3.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028) 60
10.3.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028) 61
10.4 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY 61
10.4.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022) 61
10.4.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028) 62
10.4.3 GCC COUNTRIES 63
10.4.4 TURKEY 63
10.4.5 SOUTH AFRICA 64
11 KEY PLAYERS PROFILES 65
11.1 CLARIO 65
11.1.1 CLARIO COMPANY DETAILS 65
11.1.2 CLARIO BUSINESS OVERVIEW 65
11.1.3 CLARIO CLINICAL TRIAL IMAGING INTRODUCTION 66
11.1.4 CLARIO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 68
11.1.5 CLARIO RECENT DEVELOPMENT 69
11.2 ICON 69
11.2.1 ICON COMPANY DETAILS 69
11.2.2 ICON BUSINESS OVERVIEW 70
11.2.3 ICON CLINICAL TRIAL IMAGING INTRODUCTION 70
11.2.4 ICON REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 71
11.2.5 ICON RECENT DEVELOPMENT 72
11.3 MCLAREN 72
11.3.1 MCLAREN COMPANY DETAILS 72
11.3.2 MCLAREN BUSINESS OVERVIEW 73
11.3.3 MCLAREN CLINICAL TRIAL IMAGING INTRODUCTION 73
11.3.4 MCLAREN REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 74
11.3.5 MCLAREN RECENT DEVELOPMENT 75
11.4 PAREXEL 75
11.4.1 PAREXEL COMPANY DETAILS 75
11.4.2 PAREXEL BUSINESS OVERVIEW 76
11.4.3 PAREXEL CLINICAL TRIAL IMAGING INTRODUCTION 76
11.4.4 PAREXEL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 77
11.4.5 PAREXEL RECENT DEVELOPMENT 78
11.5 BIOTELEMETRY 79
11.5.1 BIOTELEMETRY COMPANY DETAILS 79
11.5.2 BIOTELEMETRY BUSINESS OVERVIEW 79
11.5.3 BIOTELEMETRY CLINICAL TRIAL IMAGING INTRODUCTION 79
11.5.4 BIOTELEMETRY REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 80
11.5.5 BIOTELEMETRY RECENT DEVELOPMENT 81
11.6 PROSCAN IMAGING 81
11.6.1 PROSCAN IMAGING COMPANY DETAILS 81
11.6.2 PROSCAN IMAGING BUSINESS OVERVIEW 81
11.6.3 PROSCAN IMAGING CLINICAL TRIAL IMAGING INTRODUCTION 82
11.6.4 PROSCAN IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 83
11.6.5 PROSCAN IMAGING RECENT DEVELOPMENT 84
11.7 IMAGING ENDPOINTS 84
11.7.1 IMAGING ENDPOINTS COMPANY DETAILS 84
11.7.2 IMAGING ENDPOINTS BUSINESS OVERVIEW 85
11.7.3 IMAGING ENDPOINTS CLINICAL TRIAL IMAGING INTRODUCTION 85
11.7.4 IMAGING ENDPOINTS REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 87
11.7.5 IMAGING ENDPOINTS RECENT DEVELOPMENT 87
11.8 RADIANT SAGE 88
11.8.1 RADIANT SAGE COMPANY DETAILS 88
11.8.2 RADIANT SAGE BUSINESS OVERVIEW 88
11.8.3 RADIANT SAGE CLINICAL TRIAL IMAGING INTRODUCTION 88
11.8.4 RADIANT SAGE REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 89
11.9 MICRON, INC. 90
11.9.1 MICRON, INC. COMPANY DETAILS 90
11.9.2 MICRON, INC. BUSINESS OVERVIEW 90
11.9.3 MICRON, INC. CLINICAL TRIAL IMAGING INTRODUCTION 90
11.9.4 MICRON, INC. REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 91
11.9.5 MICRON, INC. RECENT DEVELOPMENT 92
11.10 INTRINSIC IMAGING 92
11.10.1 INTRINSIC IMAGING COMPANY DETAILS 92
11.10.2 INTRINSIC IMAGING BUSINESS OVERVIEW 93
11.10.3 INTRINSIC IMAGING CLINICAL TRIAL IMAGING INTRODUCTION 93
11.10.4 INTRINSIC IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 94
11.10.5 INTRINSIC IMAGING RECENT DEVELOPMENT 94
11.11 MEDIAN TECHNOLOGIES 95
11.11.1 MEDIAN TECHNOLOGIES COMPANY DETAILS 95
11.11.2 MEDIAN TECHNOLOGIES BUSINESS OVERVIEW 95
11.11.3 MEDIAN TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION 95
11.11.4 MEDIAN TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 96
11.11.5 MEDIAN TECHNOLOGIES RECENT DEVELOPMENT 97
11.12 CARDIOVASCULAR IMAGING TECHNOLOGIES 97
11.12.1 CARDIOVASCULAR IMAGING TECHNOLOGIES COMPANY DETAILS 97
11.12.2 CARDIOVASCULAR IMAGING TECHNOLOGIES BUSINESS OVERVIEW 98
11.12.3 CARDIOVASCULAR IMAGING TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION 98
11.12.4 CARDIOVASCULAR IMAGING TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 99
11.13 BANOOK MEDICAL 100
11.13.1 BANOOK MEDICAL COMPANY DETAILS 100
11.13.2 BANOOK MEDICAL BUSINESS OVERVIEW 101
11.13.3 BANOOK MEDICAL CLINICAL TRIAL IMAGING INTRODUCTION 101
11.13.4 BANOOK MEDICAL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 101
11.13.5 BANOOK MEDICAL RECENT DEVELOPMENT 102
11.14 IXICO 102
11.14.1 IXICO COMPANY DETAILS 102
11.14.2 IXICO BUSINESS OVERVIEW 103
11.14.3 IXICO CLINICAL TRIAL IMAGING INTRODUCTION 103
11.14.4 IXICO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022) 104
11.14.5 IXICO RECENT DEVELOPMENT 105
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 106
13 APPENDIX 108
13.1 RESEARCH METHODOLOGY 108
13.1.1 METHODOLOGY/RESEARCH APPROACH 108
13.1.2 DATA SOURCE 111
13.2 DISCLAIMER 114
13.3 AUTHOR DETAILS 114

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

QYResearch社のその他分野での最新刊レポート

本レポートと同じKEY WORD（clinical trial）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.